DJO Global Showcases New Bracing and Supports Products at American Academy of Orthopedic Surgeons Meeting

February 8, 2012

SAN DIEGO, CA, February 8, 2012 – DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced an aggressive expansion of its bracing and supports product portfolio with the preview of new innovative products leveraging new technologies and  designed to improve patient compliance with treatment protocols at the American Academy of Orthopedic Surgeons (“AAOS”) Meeting, taking place in San Francisco February 8-10, 2012.

“We are excited to accelerate our market leading franchises in bracing and cold therapy with four major product launches this quarter,” said Mike Mogul, President and CEO of DJO Global, Inc. “Each of these four new products represents a leap forward in design and function using new materials and technologies that make the products lighter and easier to use while remaining cost effective treatment options.”

Among the key products showcased under DJO Global’s DonJoy® brand is the groundbreaking OA Nano™, the world’s lightest off-loading brace for patients with mild to moderate osteoarthritis (“OA”) of the knee. Incorporating a new generation nano magnesium alloy (“nanoMAG”) used in industries such as aerospace, automotive, cell phones and computers, the OA Nano provides the light weight of regular magnesium with the strength needed to leverage DJO Global’s clinically proven OA Adjuster® technology and provides arthritis pain relief on the off-loading side. At only 14 ounces, the OA Nano also uses regular magnesium on the thigh and calf cuffs for easy custom adjustment. “The combination of these lightweight and functional technologies result in an OA brace you can almost not feel, which takes patient acceptance to a higher level,” said Steve Ingel, Senior Vice President, General Manager of DJO Global’s Bracing & Supports business unit.

DJO Global is also showcasing its new IceMan ® Clear3 (“clear cube”), an innovative translucent cold therapy device which is stackable and allows clinicians to instantly identify ice and water levels without the hassle of lifting the lid. This new product, which also incorporates the company’s patented semi-closed loop recirculation system, allows for controlled temperature delivery with enhanced ease of use.

In addition, DJO Global is improving the efficiency in the operating room through the launch of the X-Act ROM™ Knee and X-Act ROM™ Elbow post-operative braces, both designed for quick application following surgery and a contoured fit that can be adjusted for each patient. Both feature a new durable aluminum hinge that allows for precise range of motion and unique anti-migration foam.

These new products are expected to be available in early spring of 2012.

DJO Global will be located in booth #5279 at the AAOS meeting.

About DJO Global

DJO Global is a leading global developer, manufacturer and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management. The Company’s products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company’s medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company’s product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management and physical therapy products. The Company’s surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee and shoulder. DJO Global’s products are marketed under a portfolio of brands including Aircast®, Chattanooga, CMF™, Compex®, DonJoy®, Empi®, ProCare®, DJO® Surgical and Dr. Comfort®.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements relate to, among other things, the Company’s expectations for the timing of new product releases. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based on the Company’s current expectations and are subject to a number of risks, uncertainties and assumptions, many of which are beyond the Company’s ability to control or predict. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The important factors that could cause actual  results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to the following: the successful execution of the Company’s business strategies relative to its Bracing and Vascular, Recovery Sciences, International and Surgical Implant segments;   the successful execution of the Company’s sales strategies;  and the Company’s ability to successfully develop, license or acquire, and timely introduce and market new products or product enhancements. These and other risk factors related to DJO are detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on March 3, 2011 with the Securities and Exchange Commission. Many of the factors that will determine the outcome of the subject matter of this press release are beyond the Company’s ability to control or predict.